Remarkable polymorphism of HLA-B27: An ongoing saga

Current Rheumatology Reports

Volumn 12, Issue 5, 2010, Pages 337-341

  Khan, Muhammad Asim ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Alleles; Ankylosing spondylitis; Disease association; Heterogeneity; HLA B*2705; HLA B27; Polymorphisms; Spondyloarthropathies; Subtypes

Indexed keywords

HLA B27 ANTIGEN; INTERLEUKIN 17;

ANKYLOSING SPONDYLITIS; CD4+ T LYMPHOCYTE; CHLAMYDIASIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENTERITIS; ENTHESITIS; GENETIC HETEROGENEITY; HEART BLOCK; HELPER CELL; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; SPONDYLOARTHROPATHY; UVEITIS;

EID: 78149467815     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-010-0126-x     Document Type: Review

References (35)

1. Thorsby E: HL-A antigens and genes. I. A study of unrelated Norwegians. Vox Sang 1969, 17:81-92.
2. Khan MA: HLA-B27 and its pathogenic role. J Clin Rheumatol 2008, 14:50-52.
3. Brewerton DA, Hart FD, Nicholls A, et al.: Ankylosing spondylitis and HL-A 27. Lancet 1973, 1:904-907.
4. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM: High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973, 288:704-706.
5. ••Khan MA: HLA and spondyloarthropathies. In The HLA Complex in Biology and Medicine. Edited by Mehra N. New Delhi, India: Jaypee Brothers Medical Publishers; 2010:422-446. This is a comprehensive review on the association between HLA-B27 and AS, and polymorphism of HLA-B27 in a book just published.
6. Akkoc N, Khan MA: Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology. Edited by Weisman MH, Reveille JD, van der Heijde D. London: Mosby- Elsevier; 2006:117-131.
7. Brown MA, Jepson A, Young A, et al.: Ankylosing spondylitis in West Africans-evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 1997, 56:68-70.
8. Lopez-Larrea C, Mijiyawa M, Gonzalez S, et al.: Association of ankylosing spondylitis with HLA-B*1403 in a West African population. Arthritis Rheum 2002, 46:2968-2971.
9. Diaz-Pena R, Blanco-GelazMA, Njobvu P, et al.: Influence of HLAB* 5703 andHLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population. J Rheumatol 2008, 35:2236-2240.
10. Khan MA: Ankylosing spondylitis and heterogeneity of HLAB27. Semin Arthritis Rheum 1988, 18:134-141.
11. Khan MA: HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995, 7:263-269.
12. Khan MA: Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000, 12:235-238.
13. Khan MA, Mathieu A, Sorrentino R, Akkoc N: The pathogenic role of HLA-B27 and its subtypes in ankylosing spondylitis. Autoimmun Rev 2007, 6:183-189.
14. Taurog JD: The mystery of HLA-B27: if it isn't one thing, it's another. Arthritis Rheum 2007, 56:2478-2481.
15. ZieglerA, Loll B,Misselwitz R,Uchanska-Ziegler B: Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis. Adv Exp Med Biol 2009, 649:177-195.
16. Reveille J, Maganti R: Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. Adv Exp Med Biol 2009, 649:159-176.
17. European Bioinformatics Institute: IMGT/HLA Database. Available at http://www.ebi.ac.uk/cgi-bin/imgt/hla/allele.cgi. Accessed July 13, 2010.
18. Mou Y, Wu Z, Gu J, et al.: HLA-B27 polymorphism in patients with juvenile and adult onset ankylosing spondylitis in Southern China. Tissue Antigens 2010, 75:56-60.
19. Liu X, Hu LH, Li YR, et al.: The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China. Rheumatol Int 2010, 30:587-590.
20. Tam LS, Gu J, Yu D: Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 2010, 6:399-405. This is a comprehensive review of the pathogenetic aspects of AS.
21. Liu Y, Jiang L, Cai Q, et al.: Predominant association of HLAB* 2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens 2010, 75:61-64.
22. Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, et al.: HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLAB27- related diseases. The possible protective role of B*2707. Hum Immunol 2004, 65:1451-1454.
23. Khan MA, Kushner I, Braun WE: Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 1977, 20:909-912.
24. Feldtkeller E, Khan MA, van der Linden S, et al.: Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003, 23:61-66.
25. Khan MA: Ankylosing Spondylitis. New York: Oxford University Press; 2009. This is a recently published, concise book AS and related SpA.
26. Kim TJ, Na KS, Lee HJ, et al.: HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 2009, 27:574-579.
27. Khan MA, Kushner I, Braun WE, et al.: HLA-B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens 1978, 11:434-438.
28. Jaakkola E, Herzberg I, Laiho K, et al.: Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 2006, 65:775-780.
29. ••Thomas GP, Brown MA: Genetics and genomics of ankylosing spondylitis. Immunol Rev 2010, 233:162-180. This comprehensive review summarizes recent state-of-the art knowledge about the genetic aspects of AS.
30. Kollnberger S, Bowness P: Role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Adv Exp Med Biol 2009, 649:277-285.
31. François RJ, Braun J, Khan MA: Entheses and enthesitis: a histopathological review and relevance to spondyloarthritides. Curr Opin Rheumatol 2001, 13:255-264.
32. Adams DD, Knight JG, Ebringer A: Autoimmune diseases: solution of the environmental, immunological and genetic components with principles for immunotherapy and transplantation. Autoimmun Rev 2010, 9:525-530.
33. Stone MA, Payne U, Schentag C, et al.: Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis. Rheumatology (Oxford) 2004, 43:148-155.
34. Cragnolini JJ, Garcia-Medel N, Lopez de Castro J: Endogenous processing and presentation of T-cell epitopes from chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis. Mol Cell Proteomics 2009, 8:1850-1859.
35. Carter JD, Gerard HC, Espinoza LR, et al.: Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009, 60:1311-1316.